Comparative Bioavailability Study of Lamotrigine ER Tablets USP 50 mg

NCT05145608 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Lamotrigine ER tablet 50mg

Sponsor

Alembic Pharmaceuticals Ltd.